The Traditional Chinese Medicine (TCM) Market faces significant hurdles related to regulatory inconsistency. In 2025, nearly 40% of small-scale producers are restricted from international markets because their products do not meet the strict standardization requirements of the FDA or EMA. This fragmentation creates a "quality gap" where premium, certified brands command high prices, while...